MedPath

Polymyxin B Sulfate and Trimethoprim

Polymyxin B Sulfate andTrimethoprim Ophthalmic Solution, USP (Sterile)

Approved
Approval ID

31a7ad1f-3f58-41a0-94f0-36674285bb61

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Sep 1, 2023

Manufacturers
FDA

Preferred Pharmaceuticals Inc.

DUNS: 791119022

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Polymyxin B Sulfate and Trimethoprim Sulfate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code68788-8152
Application NumberANDA064120
Product Classification
M
Marketing Category
C73584
G
Generic Name
Polymyxin B Sulfate and Trimethoprim Sulfate
Product Specifications
Route of AdministrationOPHTHALMIC
Effective DateSeptember 1, 2023
FDA Product Classification

INGREDIENTS (7)

POLYMYXIN B SULFATEActive
Quantity: 10000 [USP'U] in 1 mL
Code: 19371312D4
Classification: ACTIM
SULFURIC ACIDInactive
Code: O40UQP6WCF
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
SODIUM CHLORIDEInactive
Code: 451W47IQ8X
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
BENZALKONIUM CHLORIDEInactive
Code: F5UM2KM3W7
Classification: IACT
TRIMETHOPRIM SULFATEActive
Quantity: 1 mg in 1 mL
Code: E377MF8EQ8
Classification: ACTIM

Drug Labeling Information

DESCRIPTION SECTION

LOINC: 34089-3Updated: 9/1/2023

DESCRIPTION

Polymyxin B sulfate and trimethoprim ophthalmic solution, USP is a sterile antimicrobial solution for topical ophthalmic use. It has pH of 4.0 to 5.5 and osmolality of 270 to 310 mOsm/kg.

Chemical Names:
Trimethoprim sulfate, 2,4-diamino-5-(3,4,5-trimethoxybenzyl) pyrimidine sulfate, is a white, odorless, crystalline powder with a molecular weight of 678.72 and the following structural formula:

Trimethoprim sulfate (Structural formula)

C28H38N8O10S Mol. Wt. 678.72

Polymyxin B sulfate is the sulfate salt of polymyxin B1 and B2 which are produced by the growth of Bacillus polymyxa (Prazmowski) Migula (Fam. Bacillaceae). It has a potency of not less than 6,000 polymyxin B units per mg, calculated on an anhydrous basis. The structural formula is:

Polymyxin B Sulfate, the sulfate salt of polymyxin B1 and B2 (Structural formula)

Each mL contains: Actives: polymyxin B sulfate equal to 10,000 polymyxin B units, trimethoprim sulfate (equivalent to trimethoprim 1 mg); Inactives: purified water, sodium chloride. Sulfuric acid and, if necessary, sodium hydroxide may be added to adjust pH (4.0 – 5.5). Preservative: benzalkonium chloride 0.004%

HOW SUPPLIED SECTION

LOINC: 34069-5Updated: 9/1/2023

HOW SUPPLIED

Polymyxin B sulfate and trimethoprim ophthalmic solution, USP* containing 10,000 polymyxin B units and 1 mg trimethoprim per mL, is supplied in a plastic bottle with a controlled drop tip and a natural cap in the following size:

NDC 68788-8152-1 10 mL

DO NOT USE IF IMPRINTED NECKBAND IS NOT INTACT.

Storage:

Store at 15°C to 25°C (59°F to 77°F). PROTECT FROM LIGHT.

*Does not meet USP packaging specification for light resistance.

RETAIN IN CARTON UNTIL TIME OF USE.

Distributed by:
Bausch & Lomb Americas Inc.
Bridgewater, NJ 08807 USA

Manufactured by:
Bausch & Lomb Incorporated
Tampa, FL 33637 USA

© 2023 Bausch & Lomb Incorporated or its affiliates

Relabeled By: Preferred Pharmaceuticals Inc.

Revised: June 2023

9117804**(Folded)**
9117904**(Flat)**

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Polymyxin B Sulfate and Trimethoprim - FDA Drug Approval Details